Literature DB >> 24782356

New population-based reference values for spinal mobility measures based on the 2009-2010 National Health and Nutrition Examination Survey.

Shervin Assassi1, Michael H Weisman, MinJae Lee, Laurie Savage, Laura Diekman, Tiffany A Graham, Mohammad H Rahbar, Joan I Schall, Lianne S Gensler, Atul A Deodhar, Daniel O Clegg, Robert A Colbert, John D Reveille.   

Abstract

OBJECTIVE: To report population-based percentile reference values for selected spinal mobility measures in a nationally representative sample of 5,001 US adults ages 20-69 years who were examined in the 2009-2010 US National Health and Nutrition Examination Survey (NHANES).
METHODS: Occiput-to-wall distance (OWD), thoracic expansion (TE), and anterior lumbar flexion (ALF; by modified Schober test) were measured by trained examiners in a standardized manner. TE was measured at the xiphisternal level, while the lower reference point for ALF was a line marked at the level of the superior margin of the lateral iliac crests. We report reference values based on the 95th percentile for the OWD and the 5th percentile for TE and ALF, as well as other summary statistics for these measures, in the study population.
RESULTS: An OWD of >0 was present in 3.8% of the participants, while 8.8% of them had out-of-range values for TE based on the commonly used threshold of 2.5 cm. The 95th percentile of the OWD measurement was 0, while the 5th percentile for TE and ALF were 1.9 cm and 2 cm, respectively. The spinal measures were significantly associated with sex, age, ethnicity, height, and body mass index (BMI). Exclusion of individuals with severe obesity (BMI >35 kg/m(2) ) changed the proposed reference values for TE and ALF to 2.2 cm and 1.9 cm, respectively.
CONCLUSION: We verified a reference value of 0 for the OWD in the general population. Using the reported population-based percentile values, new reference values for TE and ALF can be derived.
Copyright © 2014 by the American College of Rheumatology.

Entities:  

Mesh:

Year:  2014        PMID: 24782356      PMCID: PMC4146670          DOI: 10.1002/art.38692

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN: 2326-5191            Impact factor:   10.995


  18 in total

Review 1.  Associations between ankylosing spondylitis, psoriatic arthritis, Reiter's disease, the intestinal arthropathies, and Behcet's syndrome.

Authors:  J M Moll; I Haslock; I F Macrae; V Wright
Journal:  Medicine (Baltimore)       Date:  1974-09       Impact factor: 1.889

2.  New York clinical criteria for ankylosing spondylitis. A statistical evaluation.

Authors:  J M Moll; V Wright
Journal:  Ann Rheum Dis       Date:  1973-07       Impact factor: 19.103

3.  Measurement of back movement.

Authors:  I F Macrae; V Wright
Journal:  Ann Rheum Dis       Date:  1969-11       Impact factor: 19.103

4.  Normal range of spinal mobility. An objective clinical study.

Authors:  J M Moll; V Wright
Journal:  Ann Rheum Dis       Date:  1971-07       Impact factor: 19.103

5.  An objective clinical study of chest expansion.

Authors:  J M Moll; V Wright
Journal:  Ann Rheum Dis       Date:  1972-01       Impact factor: 19.103

6.  The prevalence of HLA-B27 in the US: data from the US National Health and Nutrition Examination Survey, 2009.

Authors:  John D Reveille; Rosemarie Hirsch; Charles F Dillon; Margaret D Carroll; Michael H Weisman
Journal:  Arthritis Rheum       Date:  2012-05

7.  Both structural damage and inflammation of the spine contribute to impairment of spinal mobility in patients with ankylosing spondylitis.

Authors:  Pedro Machado; Robert Landewé; Jürgen Braun; Kay-Geert A Hermann; Daniel Baker; Désirée van der Heijde
Journal:  Ann Rheum Dis       Date:  2010-05-24       Impact factor: 19.103

8.  The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis.

Authors:  J Sieper; M Rudwaleit; X Baraliakos; J Brandt; J Braun; R Burgos-Vargas; M Dougados; K-G Hermann; R Landewé; W Maksymowych; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2009-06       Impact factor: 19.103

9.  Development of a core set of domains for data collection in cohorts of patients with ankylosing spondylitis receiving anti-tumor necrosis factor-alpha therapy.

Authors:  Jane Zochling; Joachim Sieper; Désirée van der Heijde; Jürgen Braun
Journal:  J Rheumatol       Date:  2008-05-01       Impact factor: 4.666

10.  The prevalence of inflammatory back pain: population-based estimates from the US National Health and Nutrition Examination Survey, 2009-10.

Authors:  Michael H Weisman; James P Witter; John D Reveille
Journal:  Ann Rheum Dis       Date:  2012-07-11       Impact factor: 19.103

View more
  4 in total

1.  Pulmonary Function after Treatment for Childhood Cancer. A Report from the St. Jude Lifetime Cohort Study (SJLIFE).

Authors:  Daniel M Green; Liang Zhu; Mingjuan Wang; Kirsten K Ness; Matthew J Krasin; Nickhill H Bhakta; M Beth McCarville; Saumini Srinivasan; Dennis C Stokes; DeoKumar Srivastava; Rohit Ojha; Kyla Shelton; Ching-Hon Pui; Gregory T Armstrong; Daniel A Mulrooney; Monika Metzger; Sheri L Spunt; Fariba Navid; Andrew M Davidoff; Bhaskar N Rao; Leslie L Robison; Melissa M Hudson
Journal:  Ann Am Thorac Soc       Date:  2016-09

2.  Ultrasound-guided epidural block in axial spondyloarthritis patients with limited spine mobility: a randomized controlled trial.

Authors:  A M Elsaman; A Hamed; A R Radwan
Journal:  Korean J Pain       Date:  2021-01-01

3.  From bowel inflammation to the bone and joints: musculoskeletal examination in inflammatory bowel disease (IBD).

Authors:  Samane Tavassoli; Iman Shahabinasab; Alireza Norouzi; Taghi Amiriani; Nafiseh Abdolahi; Somayeh Livani; Seyed Farzam Mirkamali; Honey Sadat Mirkarimi; Fazel Isapanah Amlashi; Sima Besharat
Journal:  BMC Musculoskelet Disord       Date:  2021-12-04       Impact factor: 2.362

4.  Standard values of the upper body posture and postural control: a study protocol.

Authors:  Daniela Ohlendorf; Christoph Mickel; Natalie Filmann; Eileen M Wanke; David A Groneberg
Journal:  J Occup Med Toxicol       Date:  2016-07-16       Impact factor: 2.646

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.